Comparative Effects of Enalapril, Enalaprilic Acid and Captopril in Blocking Angiotensin I-Induced Pressor and Dipsogenic Responses in Spontaneously Hypertensive Rats

References

• Assad M M, Antonaccio M J. Vascular wall renin in spontaneously hypertensive rats: Potential relevance to hypertension maintenance and antihypertensive effect of captopril. Hypertension 1982; 4: 487–493
   PubMed Web of Science ®Google Scholar
• Antonaccio M J, Assad M, Rubin B, Horovitz Z P. Angiotensin Converting Enzyme Inhibitors, Z P Horovitz. Urban and Schwarzenberg, Baltimore, Munich 1981; p. 161
   Google Scholar
• Antonaccio M J, McGill M. Comparative effects of captopril and MK-421 on sympathetic function in spontaneously hypertensive rats. Am J Cardiol 1982; 49: 1533–1534
   PubMed Web of Science ®Google Scholar
• Baum T, Becker F T, Bertz E J. Attenuation of pressor responses to intraventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats. Life Sci 1983; 32: 1297–1303
   PubMed Web of Science ®Google Scholar
• Boomsma F, de Bruyn J HB, Derkx F HM, Schalekamp M ADH. Opposite effects of captopril on angiotensin I converting enzyme activity and concentration relation between enzyme inhibition and long-term blood pressure response. Clin Sci 1981; 60: 491–498
   PubMed Web of Science ®Google Scholar
• Cohen M L, Kurz K D. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther 1982; 220: 63–69
   PubMed Web of Science ®Google Scholar
• Cohen M L, Kurz K D. Captopril and MK-421: Stability on storage distribution to the central nervous system and onset of activity. Fed Proc 1983; 42: 171–175
   PubMedGoogle Scholar
• Cohen M L, Kurz K D, Schenck K W. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422. J Pharmacol Exp Ther 1983; 226: 192–196
   PubMed Web of Science ®Google Scholar
• Colquhoun D. Lectures on Biostatistics. Oxford University Press, London 1971
   Google Scholar
• Dunnett C W. New tables for multiple comparisons with a control. Biometrics 1964; 20: 492
   Google Scholar
• Epstein A N, Fitzsimons J T, Johnson A K. Peptide antagonists of the renin-angiotensin system and the elucidation of the receptors for angiotensin-induced drinking. J Physiol (London) 1974; 238: 34P
   Google Scholar
• Evered M D, Robinson M M, Richardson M A. Captopril given intracerebroventricularly subcutaneously or by gavage inhibits angiotensin converting enzyme activity in the rat brain. Eur J Pharmacol 1980; 68: 443–449
   PubMed Web of Science ®Google Scholar
• Ganten D, Speck G. The brain renin-angiotensin system: A model for the synthesis of peptides in the brain. Biochem Pharmacol 1978; 27: 2379–2389
   PubMed Web of Science ®Google Scholar
• Ganten D, Unger T, Rockhold R, Schaz K, Speck G. Cardiovascular Medicine, A Albertini, M DaPrada, B Peskar. Biochemical Press, Elsevier/North Holland 1979; p. 33
   Google Scholar
• Garst J B, Koletsky S, Wisenbaugh P E, Hadady M, Matthews D. Arterial wall renin and renal venous renin in the hypertensive rat. Clin Sci 1979; 56: 41–46
   PubMed Web of Science ®Google Scholar
• Heald A F, Ita C E. Distribution in rats of an inhibitor of angiotensin converting enzyme, SQ 14, 225, a studied by whole-body autoradiography and liquid scintillation counting. Pharmacologist 1977; 19: 129
   Google Scholar
• Hutchinson J S, Mendelsohn F A.O. Hypertensive effects of captopril administered centrally in intact conscious spontaneously hypertensive rats and peripherally in anephritic anesthetized spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1980; 7: 555–558
   PubMed Web of Science ®Google Scholar
• Hutchinson J S, Mendelsohn F AO, Doyle A E. Blood pressure responses of conscious normotensive and spontaneously hypertensive rats to intracerebroventricular and peripheral administration of captopril. Hypertension 1980; 2: 546–550
   PubMed Web of Science ®Google Scholar
• Hutchinson J S, Hooper R, Jarrott B, Mendelsohn F AO, Louis W J. Captopril does not cross the blood cerebrospinal fluid barrier in the spontaneously hypertensive rat after single intravenous injection. Proceedings of the 4th International Symposium on rats with spontaneous hypertension and related studies, Toronto, 1982, 691–693
   Google Scholar
• Mann J FE, Phillips M I, Dietz R, Haebara H, Ganten D. Effects of central and peripheral angiotensin blockade in hypertensive rats. Am J Physiol 1978; 234: H629–H637
   PubMed Web of Science ®Google Scholar
• Mann J FE, Rascher W, Dietz R, Schomig A, Ganten D. Effects of an orally active converting enzyme inhibitor, SQ 14, 225, on pressor responses to angiotensin administered into the brain ventricles of spontenously hypeprtensive rats. Clin Sci 1979; 56: 585–589
   PubMed Web of Science ®Google Scholar
• Myers R D. Methods in Psychobiology, R D Myers. Academic Press, New York 1971; Vol. 1: p. 27–67
   Google Scholar
• Patchett A, Harris E, Tristram E, Wyvratt M, Wu M T, Taub D, Peterson E, Ikeler T, ten Broeke J, Payne L, Ondeyka D, Thorsett E, Greenlee W, Lohr N, Maycock A, Hoffsommer R, Joshua H, Ruyle W, Rothrock J, Aster S, Robinson F M, Sweet C S, Ulm E H, Gross D M, Vassel T C, Stone C A. A new class of angiotensin converting enzyme inhibitors. Nature 1980; 288: 280–283
   PubMed Web of Science ®Google Scholar
• Pellegrino L J, Pellegrino A S, Cushman A J. A Stereotaxic Atlas of the Rat Brain (2nd edition). Plenum Press, New York 1979
   Google Scholar
• Phillips M I. Angiotensin in the brain. Neuroendocrinology 1978; 25: 354–377
   PubMed Web of Science ®Google Scholar
• Phillips M I. New evidence for brain angiotensin and for its role in hypertension. Fed Proc 1983; 42: 2667–2672
   PubMedGoogle Scholar
• Reid I A, Ramsay D J. The effects of intracerebroventricular administration of renin on drinking and blood pressure. Endocrinology 1975; 97: 536–542
   PubMed Web of Science ®Google Scholar
• Reid I A. The brain renin-angiotensin system: A critical analysis. Fed Proc 1979; 38: 2255–2259
   PubMedGoogle Scholar
• Stamler J F, Brody M J, Phillips M I. The central and peripheral effects of captopril (SQ 14 225) on the arterial pressure of spontaneously hypertensive rats. Brain Res 1980; 186: 499–503
   PubMed Web of Science ®Google Scholar
• Sweet C S, Arbegast P T, Gaul S L, Blaine E H, Gross D M. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats. Eur J Pharmacol 1981; 76: 167–176
   PubMed Web of Science ®Google Scholar
• Sweet C S, Gross D M, Arbegast P T, Gaul S L, Britt P M, Ludden C T, Weitz D, Stone C A. Antihypertensive activity of N-[(S)-1-(ethoxycarbopyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421) an orally active converting enzyme inhibitor. J Pharmacol Exp Ther 1981; 216: 558–566
   PubMed Web of Science ®Google Scholar
• Sweet C S. Pharmacological properties of the converting enzyme inhibitor: Enalapril maleate (MK-421). Fed Proc 1983; 42: 167–170
   PubMedGoogle Scholar
• Tocco D J, de Luna F A, Duncan A EW, Vassil T C, Ulm E H. The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab Dispos 1982; 10: 15–19
   PubMed Web of Science ®Google Scholar
• Unger T, Kaufmann-Buhler I, Scholkens B, Ganten D. Brain converting enzyme inhibition: A possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Fur J Pharmacol 1981; 70: 467–478
   Google Scholar
• Unger T, Schull B, Hubner D, Yukimura T, Lang R E, Rascher W, Ganten D. Plasma converting enzyme activity does not reflect effectiveness of oral treatment with captopril. Eur J Pharmacol 1918; 72: 255–259
   Google Scholar
• Vollmer R R, Boccagno J A. Central cardiovascular effects of SQ 14, 225, an angiotensin converting enzyme inhibitor in chloro-lose-anesthetized cats. Eur J Pharmacol 1977; 45: 117–125
   PubMed Web of Science ®Google Scholar
• Waeber B, Brunner H R, Brunner D B, Curtet A L, Turini G A, Gavras H. Discrepancy between antihyipertensive effect and angiotensin converting enzyme inhibition by captoprll. Hypertension 1980; 2: 236–242
   PubMed Web of Science ®Google Scholar